Acute experimental changes in mood state regulate immune function in relation to central opioid neurotransmission: A model of human CNS-peripheral inflammatory interaction

Molecular Psychiatry

Volumn 21, Issue 2, 2016, Pages 243-251

  Prossin, A R ^a   Koch, A E ^b,c   Campbell, P L ^b   Barichello, T ^a,d   Zalcman, S S ^e   Zubieta, J K ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c Ann Arbor Veteran Administration Health Center   (United States)

^d UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^e RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARFENTANIL; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 18; MU OPIATE RECEPTOR; OPIATE; IMMUNOLOGIC FACTOR; OPRM1 PROTEIN, HUMAN;

ANTERIOR CINGULATE; ARTICLE; BRAIN CORTEX; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEART DISEASE; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; MAJOR DEPRESSION; MOOD; NEUROIMAGING; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; PAIN; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SADNESS; VOLUNTEER; ADULT; AFFECT; AMYGDALA; BRAIN; CINGULATE GYRUS; COMPARATIVE STUDY; EMOTION; METABOLISM; PAIN MEASUREMENT; PHYSIOLOGY; PROCEDURES; SYNAPTIC TRANSMISSION;

ADULT; AFFECT; AMYGDALA; BRAIN; DEPRESSIVE DISORDER, MAJOR; EMOTIONS; FEMALE; GYRUS CINGULI; HUMANS; IMMUNOLOGIC FACTORS; INTERLEUKIN-18; PAIN; PAIN MEASUREMENT; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, OPIOID, MU; SYNAPTIC TRANSMISSION;

EID: 84955210171     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2015.110     Document Type: Article

References (52)

1. Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J 2006; 27: 2763-2774.
2. Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med 2004; 66: 802-813.
3. Bossu P, Salani F, Cacciari C, Picchetto L, Cao M, Bizzoni F et al. Disease outcome, alexithymia and depression are differently associated with serum IL-18 levels in acute stroke. Curr Neurovasc Res 2009; 6: 163-170.
4. Merendino RA, Di Rosa AE, Di Pasquale G, Minciullo PL, Mangraviti C, Costantino A et al. Interleukin-18 and CD30 serum levels in patients with moderate-severe depression. Mediators Inflamm 2002; 11: 265-267.
5. Prossin AR, Koch AE, Campbell PL, McInnis MG, Zalcman SS, Zubieta JK. Association of plasma interleukin-18 levels with emotion regulation and mu-opioid neurotransmitter function in major depression and healthy volunteers. Biol Psychiatry 2011; 69: 808-812.
6. Blankenberg S, Tiret L, Bickel C, Peetz D, Cambien F, Meyer J et al. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 2002; 106: 24-30.
7. Dimsdale JE. Psychological stress and cardiovascular disease. J Am Coll Cardiol 2008; 51: 1237-1246.
8. Mallat Z, Corbaz A, Scoazec A, Graber P, Alouani S, Esposito B et al. Interleukin-18/ interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability. Circulation Res 2001; 89: E41-E45.
9. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008; 9: 46-56.
10. Opstad TB, Pettersen AA, Arnesen H, Seljeflot I. The co-existence of the IL-18 +183A/G and MMP-9-1562 C/T polymorphisms is associated with clinical events in coronary artery disease patients. PLoS One 2013; 8: e74498.
11. Kennedy SE, Koeppe RA, Young EA, Zubieta JK. Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women. Arch Gen Psychiatry 2006; 63: 1199-1208.
12. Dinarello CA. Interleukin-18. Methods 1999; 19: 121-132.
13. Sims JE, Smith DE. The IL-1 family: regulators of immunity. Nat Rev Immunol 2010; 10: 89-102.
14. Puren AJ, Fantuzzi G, Dinarello CA. Gene expression, synthesis, and secretion of interleukin 18 and interleukin 1beta are differentially regulated in human blood mononuclear cells and mouse spleen cells. Proc Natl Acad Sci USA 1999; 96: 2256-2261.
15. Prinz M, Hanisch UK. Murine microglial cells produce and respond to interleukin-18. J Neurochem 1999; 72: 2215-2218.
16. Conti B, Park LC, Calingasan NY, Kim Y, Kim H, Bae Y et al. Cultures of astrocytes and microglia express interleukin 18. Brain Res Mol Brain Res 1999; 67: 46-52.
17. Conti B, Sugama S, Kim Y, Tinti C, Kim H, Baker H et al. Modulation of IL-18 production in the adrenal cortex following acute ACTH or chronic corticosterone treatment. Neuroimmunomodulation 2000; 8: 1-7.
18. Conti B, Jahng JW, Tinti C, Son JH, Joh TH. Induction of interferon-gamma inducing factor in the adrenal cortex. J Biol Chem 1997; 272: 2035-2037.
19. Sugama S, Cho BP, Baker H, Joh TH, Lucero J, Conti B. Neurons of the superior nucleus of the medial habenula and ependymal cells express IL-18 in rat CNS. Brain Res 2002; 958: 1-9.
20. Wang N, Sugama S, Conti B, Teramoto A, Shibasaki T. Interleukin-18 mRNA expression in the rat pituitary gland. J Neuroimmunol 2006; 173: 117-125.
21. Dinarello CA. IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 1999; 103: 11-24.
22. Reichwald K, Jorgensen TZ, Tougaard P, Skov S. TL1A induces TCR independent IL-6 and TNF-alpha production and growth of PLZF(+) leukocytes. PLoS One 2014; 9: e85793.
23. Miller AH, Ancoli-Israel S, Bower JE, Capuron L, Irwin MR. Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol 2008; 26: 971-982.
24. Maes M, Anderson G, Kubera M, Berk M. Targeting classical IL-6 signalling or IL-6 trans-signalling in depression? Expert Opin Ther Targets 2014; 18: 495-512.
25. Kastenmuller W, Torabi-Parizi P, Subramanian N, Lammermann T, Germain RN. A spatially-organized multicellular innate immune response in lymph nodes limits systemic pathogen spread. Cell 2012; 150: 1235-1248.
26. van de Veerdonk FL, Netea MG, Dinarello CA, Joosten LA. Inflammasome activation and IL-1beta and IL-18 processing during infection. Trends Immunol 2011; 32: 110-116.
27. Peterson PK, Molitor TW, Chao CC. The opioid-cytokine connection. J Neuroimmunol 1998; 83: 63-69.
28. Rogers TJ, Peterson PK. Opioid G protein-coupled receptors: signals at the crossroads of inflammation. Trends Immunol 2003; 24: 116-121.
29. Ruzicka BB, Akil H. The interleukin-1beta-mediated regulation of proenkephalin and opioid receptor messenger RNA in primary astrocyte-enriched cultures. Neuroscience 1997; 79: 517-524.
30. Miyoshi K, Obata K, Kondo T, Okamura H, Noguchi K. Interleukin-18-mediated microglia/astrocyte interaction in the spinal cord enhances neuropathic pain processing after nerve injury. J Neurosci 2008; 28: 12775-12787.
31. Sugama S, Kim Y, Baker H, Tinti C, Kim H, Joh TH et al. Tissue-specific expression of rat IL-18 gene and response to adrenocorticotropic hormone treatment. J Immunol 2000; 165: 6287-6292.
32. Yamakawa K, Matsunaga M, Isowa T, Kimura K, Kasugai K, Yoneda M et al. Transient responses of inflammatory cytokines in acute stress. Biol Psychol 2009; 82: 25-32.
33. Lawson LJ, Perry VH, Gordon S. Turnover of resident microglia in the normal adult mouse brain. Neuroscience 1992; 48: 405-415.
34. Chao CC, Hu S, Shark KB, Sheng WS, Gekker G, Peterson PK. Activation of mu opioid receptors inhibits microglial cell chemotaxis. J Pharmacol Exp Ther 1997; 281: 998-1004.
35. Bonnet MP, Beloeil H, Benhamou D, Mazoit JX, Asehnoune K. The mu opioid receptor mediates morphine-induced tumor necrosis factor and interleukin-6 inhibition in toll-like receptor 2-stimulated monocytes. Anesth Analg 2008; 106: 1142-1149.
36. Prossin AR, Zalcman SS, Heitzeg MM, Koch AE, Campbell PL, Phan KL et al. Dynamic Interactions Between Plasma IL-1 Family Cytokines and Central Endogenous Opioid Neurotransmitter Function in Humans. Neuropsychopharmacology 2014; 40: 554-565.
37. Prossin AR, Love TM, Koeppe RA, Zubieta JK, Silk KR. Dysregulation of Regional Endogenous Opioid Function in Borderline Personality Disorder. Am J Psychiatry 2010; 167: 925-933.
38. Zubieta JK, Ketter TA, Bueller JA, Xu Y, Kilbourn MR, Young EA et al. Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission. Arch Gen Psychiatry 2003; 60: 1145-1153.
39. Velten E Jr. A laboratory task for induction of mood states. Behav Res Ther 1968; 6: 473-482.
40. George MS, Ketter TA, Parekh PI, Herscovitch P, Post RM. Gender differences in regional cerebral blood flow during transient self-induced sadness or happiness. Biological psychiatry 1996; 40: 859-871.
41. Pardo JV, Pardo PJ, Raichle ME. Neural correlates of self-induced dysphoria. Am J Psychiatry 1993; 150: 713-719.
42. First MB, Spitzer R. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) 1995.
43. Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: The PANAS scales. J Pers Soc Psychol 1988; 54: 1063-1070.
44. Friston KJ WK, Frackowiak RSJ, Mazziotta JC, Evans AC. Assessing the significance of focal activations using their spatial extent. Hum Brain Mapp 1994; 1: 210-220.
45. Faul F, Erdfelder E, Lang AG, Buchner A. GPower 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007; 39: 175-191.
46. Buller KM, Crane JW, Day TA. The central nucleus of the amygdala; a conduit for modulation of HPA axis responses to an immune challenge? Stress 2001; 4: 277-287.
47. Hayes, AF, Preacher KJ, Myers TA. Mediation and the estimation of indirect effects in political communication researchIn:Bucy EPH, R L(eds). Sourcebook for Political Communication Research: Methods, Measures, and Analytical Techniques. Routledge: NY, USA, 2011.
48. Ribeiro SC, Kennedy SE, Smith YR, Stohler CS, Zubieta JK. Interface of physical and emotional stress regulation through the endogenous opioid system and mu-opioid receptors. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 1264-1280.
49. Day HE, Akil H. Differential pattern of c-fos mRNA in rat brain following central and systemic administration of interleukin-1-beta: implications for mechanism of action. Neuroendocrinology 1996; 63: 207-218.
50. Day HE, Curran EJ, Watson SJ Jr., Akil H. Distinct neurochemical populations in the rat central nucleus of the amygdala and bed nucleus of the stria terminalis: evidence for their selective activation by interleukin-1beta. J Comp Neurol 1999; 413: 113-128.
51. Liberzon I, Zubieta JK, Fig LM, Phan KL, Koeppe RA, Taylor SF. mu-Opioid receptors and limbic responses to aversive emotional stimuli. Proc Natl Acad Sci USA 2002; 99: 7084-7089.
52. Davis M, Whalen PJ. The amygdala: vigilance and emotion. Mol Psychiatry 2001; 6: 13-34.